The event emphasizes additional measures for obesity therapy.

How Prime Therapeutics/Magellan Rx Management reimagines pharmacy to do what's right.

Report encourages providers to consider health contexts and lifestyle modifications as well as personal preferences and current guidelines when prescribing GLP-1s for weight loss

At Pharmacy Benefit Management Institute (PBMI) annual conference, Prime received two awards: one for cost savings, another for leadership.

Prime Therapeutics is committed to simplifying the patient journey for those with complex conditions through its industry-leading HighTouchRx product

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Magellan Rx first to innovate with Medicaid VBC solutions for states grappling with the high cost of novel cell and gene therapies

Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members